{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "18",
                "@timestamp": "2023-01-18T05:34:17.000017-05:00",
                "@year": "2023",
                "@month": "01"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "07"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Bamrasnaradura Infectious Diseases Institute"},
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn Academic Advancement",
                    "xocs:funding-id": "DPG6180001"
                },
                {"xocs:funding-agency-matched-string": "Thai Red Cross AIDS Research Centre"}
            ],
            "xocs:funding-addon-generated-timestamp": "2021-06-03T05:14:51.893Z",
            "xocs:funding-text": [
                {"$": "This study was supported by the Royal Golden Jubilee PhD Program, Thailand Research Fund grant PHD/0046/2560 , and the Chulalongkorn Academic Advancement into its 2nd Century Project grant DPG6180001 ."},
                {"$": "This study was supported by the Royal Golden Jubilee PhD Program, Thailand Research Fund grant PHD/0046/2560, and the Chulalongkorn Academic Advancement into its 2nd Century Project grant DPG6180001. The authors thank all staff at the HIV-NAT, Thai Red Cross AIDS Research Centre, and the Bamrasnaradura Infectious Diseases Institute for their support."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Department of Pharmaceutical Care"},
                                {"$": "Faculty of Pharmacy"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "103084327"
                            },
                            "@affiliation-instance-id": "S0149291820302319-a22a7eb5c812e3e1ffa503f7635e7d97",
                            "ce:source-text": "Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand",
                            "@dptid": "103084327"
                        },
                        "author": [
                            {
                                "ce:given-name": "Piyawat",
                                "preferred-name": {
                                    "ce:given-name": "Piyawat",
                                    "ce:initials": "P.",
                                    "ce:surname": "Chaivichacharn",
                                    "ce:indexed-name": "Chaivichacharn P."
                                },
                                "@author-instance-id": "S0149291820302319-54fc4b63f1146c1b17eaa284c6e81392",
                                "@seq": "1",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PharmD",
                                "ce:surname": "Chaivichacharn",
                                "@auid": "57216855353",
                                "ce:indexed-name": "Chaivichacharn P."
                            },
                            {
                                "ce:given-name": "Baralee",
                                "preferred-name": {
                                    "ce:given-name": "Baralee",
                                    "ce:initials": "B.",
                                    "ce:surname": "Punyawudho",
                                    "ce:indexed-name": "Punyawudho B."
                                },
                                "@author-instance-id": "S0149291820302319-136e2c208b24f37cba780d8fa4d65e00",
                                "@seq": "7",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Punyawudho",
                                "@auid": "23976628300",
                                "ce:indexed-name": "Punyawudho B."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60016965",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "HIV-NAT"},
                                {"$": "Thai Red Cross AIDS Research Centre"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60016965"},
                                {"@afid": "60031780"}
                            ],
                            "@affiliation-instance-id": "S0149291820302319-a4c5accd899447c6ef9c7233dbbb0a20",
                            "ce:source-text": "HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"
                        },
                        "author": [
                            {
                                "ce:given-name": "Anchalee",
                                "preferred-name": {
                                    "ce:given-name": "Anchalee",
                                    "ce:initials": "A.",
                                    "ce:surname": "Avihingsanon",
                                    "ce:indexed-name": "Avihingsanon A."
                                },
                                "@author-instance-id": "S0149291820302319-b3ca3545e995594af07043fc805a4e7f",
                                "@seq": "2",
                                "ce:initials": "A.",
                                "@date-locked": "2023-01-18T05:16:58.450",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD, PhD",
                                "ce:surname": "Avihingsanon",
                                "@auid": "57196347321",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            {
                                "ce:given-name": "Sasiwimol",
                                "preferred-name": {
                                    "ce:given-name": "Sasiwimol",
                                    "ce:initials": "S.",
                                    "ce:surname": "Ubolyam",
                                    "ce:indexed-name": "Ubolyam S."
                                },
                                "@author-instance-id": "S0149291820302319-f079af1db651cc3b97ba57389b3b0861",
                                "@seq": "4",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Ubolyam",
                                "@auid": "6602454026",
                                "ce:indexed-name": "Ubolyam S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Tuberculosis Research Unit"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@affiliation-instance-id": "S0149291820302319-467d670de10636f5e5f1d5d8967cc89f",
                            "ce:source-text": "Tuberculosis Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Anchalee",
                            "preferred-name": {
                                "ce:given-name": "Anchalee",
                                "ce:initials": "A.",
                                "ce:surname": "Avihingsanon",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            "@author-instance-id": "S0149291820302319-b3ca3545e995594af07043fc805a4e7f",
                            "@seq": "2",
                            "ce:initials": "A.",
                            "@date-locked": "2023-01-18T05:16:58.450",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Avihingsanon",
                            "@auid": "57196347321",
                            "ce:indexed-name": "Avihingsanon A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "Mueang Nonthaburi",
                            "@afid": "60015728",
                            "@country": "tha",
                            "organization": [
                                {"$": "Bamrasnaradura Infectious Diseases Institute"},
                                {"$": "Ministry of Public Health"}
                            ],
                            "affiliation-id": {
                                "@afid": "60015728",
                                "@dptid": "103815566"
                            },
                            "@affiliation-instance-id": "S0149291820302319-dd75ff6722978eec11aac5574980dde3",
                            "ce:source-text": "Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Mueang Nonthaburi, Thailand",
                            "@dptid": "103815566"
                        },
                        "author": [{
                            "ce:given-name": "Weerawat",
                            "preferred-name": {
                                "ce:given-name": "Weerawat",
                                "ce:initials": "W.",
                                "ce:surname": "Manosuthi",
                                "ce:indexed-name": "Manosuthi W."
                            },
                            "@author-instance-id": "S0149291820302319-64fade6716ff2245692aafb35cda8a61",
                            "@seq": "3",
                            "ce:initials": "W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Manosuthi",
                            "@auid": "57225766218",
                            "ce:indexed-name": "Manosuthi W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence for Medical Genomics"},
                                {"$": "Department of Pediatrics"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "104425637"
                            },
                            "@affiliation-instance-id": "S0149291820302319-33fc218d60df05efe6896060493017ae",
                            "ce:source-text": "Center of Excellence for Medical Genomics, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "104425637"
                        },
                        "author": [
                            {
                                "ce:given-name": "Siraprapa",
                                "preferred-name": {
                                    "ce:given-name": "Siraprapa",
                                    "ce:initials": "S.",
                                    "ce:surname": "Tongkobpetch",
                                    "ce:indexed-name": "Tongkobpetch S."
                                },
                                "@author-instance-id": "S0149291820302319-0304a6f8d7f02a7693a92a8716d4df4a",
                                "@seq": "5",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Tongkobpetch",
                                "@auid": "6504831231",
                                "ce:indexed-name": "Tongkobpetch S."
                            },
                            {
                                "ce:given-name": "Vorasuk",
                                "preferred-name": {
                                    "ce:given-name": "Vorasuk",
                                    "ce:initials": "V.",
                                    "ce:surname": "Shotelersuk",
                                    "ce:indexed-name": "Shotelersuk V."
                                },
                                "@author-instance-id": "S0149291820302319-09734d5730c758fdcc9c9f9ad2dce323",
                                "@seq": "6",
                                "ce:initials": "V.",
                                "@date-locked": "2021-03-08T07:32:25.992",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Shotelersuk",
                                "@auid": "7003738743",
                                "ce:indexed-name": "Shotelersuk V."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence for Genomics and Precision Medicine"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "123388609"
                                },
                                {"@afid": "60031780"}
                            ],
                            "@affiliation-instance-id": "S0149291820302319-1541c087f685149f49023a1d22a7eb44",
                            "ce:source-text": "Center of Excellence for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand",
                            "@dptid": "123388609"
                        },
                        "author": [
                            {
                                "ce:given-name": "Siraprapa",
                                "preferred-name": {
                                    "ce:given-name": "Siraprapa",
                                    "ce:initials": "S.",
                                    "ce:surname": "Tongkobpetch",
                                    "ce:indexed-name": "Tongkobpetch S."
                                },
                                "@author-instance-id": "S0149291820302319-0304a6f8d7f02a7693a92a8716d4df4a",
                                "@seq": "5",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Tongkobpetch",
                                "@auid": "6504831231",
                                "ce:indexed-name": "Tongkobpetch S."
                            },
                            {
                                "ce:given-name": "Vorasuk",
                                "preferred-name": {
                                    "ce:given-name": "Vorasuk",
                                    "ce:initials": "V.",
                                    "ce:surname": "Shotelersuk",
                                    "ce:indexed-name": "Shotelersuk V."
                                },
                                "@author-instance-id": "S0149291820302319-09734d5730c758fdcc9c9f9ad2dce323",
                                "@seq": "6",
                                "ce:initials": "V.",
                                "@date-locked": "2021-03-08T07:32:25.992",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Shotelersuk",
                                "@auid": "7003738743",
                                "ce:indexed-name": "Shotelersuk V."
                            }
                        ]
                    }
                ],
                "citation-title": "Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic\u2013Pharmacogenetic Model of HIV-infected Patients in Thailand",
                "abstracts": "Â© 2020 Elsevier Inc.Purpose: Efavirenz exhibits high interindividual variability in plasma concentrations, leading to unpredictable efficacy and toxicity. Polymorphism of CYP2B6 516G > T has been found to predominantly contribute to efavirenz variability. However, dosage recommendations incorporating CYP2B6 516G > T polymorphism have not been investigated in the Thai population. This study aimed to develop a population model of the pharmacokinetic properties of efavirenz, and to investigate the impact of patients' characteristics and CYP2B6 516G > T polymorphism on the pharmacokinetic properties of efavirenz. Model-based simulations were performed to provide genotype-based dosage optimization in a Thai population. Methods: Plasma efavirenz concentrations measured at 12 h post-dose in 360 Thai HIV-infected patients with and without tuberculosis were analyzed by the nonlinear mixed-effects modeling approach. A 1-compartment model with first-order absorption and elimination was used for describing the pharmacokinetic properties of efavirenz. Findings: The allele frequency of CYP2B6 516G > T was 34.17%. The efavirenz oral clearance were 11.9, 8.0, and 2.8 L/h in patients weighing 57 kg and having the CYP2B6 516 GG, 516 GT, and 516 TT genotypes, respectively. The use of rifampicin increased efavirenz oral clearance by 28%. The results from the simulations suggest that efavirenz dosages of 400, 300, and 100 mg once daily in Thai HIV mono-infected patients, and 800, 600, and 200 mg once daily in HIV/tuberculosis co-infected patients carrying CYP2B6 516 GG, 516 GT, and 516 TT, respectively. Implication: The results from this study provide a rationale for efavirenz dose adjustment based on CYP2B6 516G > T polymorphism in Thai HIV-infected patients, which could help to improve treatment outcomes in this population. ClinicalTrials.gov identifier: NCT01138267.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Chiang Mai",
                        "organization": [
                            {"$": "Department of Pharmaceutical Care"},
                            {"$": "Faculty of Pharmacy"},
                            {"$": "Chiang Mai University"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Baralee",
                        "ce:initials": "B.",
                        "ce:degrees": "PhD",
                        "ce:surname": "Punyawudho",
                        "ce:indexed-name": "Punyawudho B."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "CYP2B6 516G>T",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Dose optimization",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Efavirenz",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "HIV",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Population pharmacokinetics\u2013pharmacogenetics",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Thailand",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "www.elsevier.com/locate/clinthera",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Clinical Therapeutics",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "42",
                            "@issue": "7"
                        },
                        "pagerange": {
                            "@first": "1234",
                            "@last": "1245"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Clinical Therapeutics",
                    "publicationdate": {
                        "month": "07",
                        "year": "2020",
                        "date-text": "July 2020",
                        "day": "01"
                    },
                    "codencode": "CLTHD",
                    "sourcetitle-abbrev": "Clin. Ther.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "1879114X",
                            "@type": "electronic"
                        },
                        {
                            "$": "01492918",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "Excerpta Medica Inc."},
                    "@srcid": "29712"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "22",
                                    "classification-description": "Human Genetics"
                                },
                                {
                                    "classification-code": "30",
                                    "classification-description": "Clinical and Experimental Pharmacology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "3004"},
                                {"$": "2736"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "PHAR"},
                                {"$": "MEDI"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "330207-11-9",
                                    "chemical-name": "cytochrome P450 2B6"
                                },
                                {
                                    "cas-registry-number": "154598-52-4",
                                    "chemical-name": "efavirenz"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Alkynes"},
                                {"chemical-name": "Anti-HIV Agents"},
                                {"chemical-name": "Benzoxazines"},
                                {"chemical-name": "Cyclopropanes"},
                                {"chemical-name": "Cytochrome P-450 CYP2B6"},
                                {"chemical-name": "efavirenz"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was supported by the Royal Golden Jubilee PhD Program, Thailand Research Fund grant PHD/0046/2560, and the Chulalongkorn Academic Advancement into its 2nd Century Project grant DPG6180001. The authors thank all staff at the HIV-NAT, Thai Red Cross AIDS Research Centre, and the Bamrasnaradura Infectious Diseases Institute for their support.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-acronym": "RGJ-Ph.D. programme",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Royal Golden Jubilee (RGJ) Ph.D. Programme"
                            },
                            "grant-agency-id": "501100012309"
                        },
                        {
                            "grant-id": "PHD/0046/2560",
                            "grant-acronym": "TRF",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Thailand Research Fund"
                            },
                            "grant-agency-id": "501100004396"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYS"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "25",
                    "@timestamp": "BST 03:36:40",
                    "@year": "2020",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2005976428",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "925872926",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200417826",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "32451120",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2020193941",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "2020116692",
                            "@idtype": "REAXYS"
                        },
                        {
                            "$": "20201087058",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2020180740",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20201774248",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85085047562",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85085047562",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "631870783",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76309799",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S0149291820302319",
                    "ce:ern": "pii:S0149291820302319",
                    "ce:doi": "10.1016/j.clinthera.2020.04.013"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "43",
                "reference": [
                    {
                        "ref-fulltext": "Department of Disease Control, Thailand ministry of public Health. Thailand Natl Guidel HIV/AIDS Treat Prev 1 (2017), 1\u2013526. (Accessed 14 October 2019)",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Thailand ministry of public Health"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085031691",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "526"
                                }
                            },
                            "ref-text": "(Accessed 14 October 2019)",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "@_fa": "true",
                                "ce:surname": "Department of Disease Control",
                                "ce:indexed-name": "Department of Disease Control"
                            }]},
                            "ref-sourcetitle": "Thailand Natl Guidel HIV/AIDS Treat Prev"
                        },
                        "ce:source-text": "Department of Disease Control, Thailand ministry of public Health. Thailand Natl Guidel HIV/AIDS Treat Prev. 2017. Available at: aidssti.ddc.moph.go.th/contents/download/1768"
                    },
                    {
                        "ref-fulltext": "Marzolini, C., Telenti, A., Decosterd, L.A., Greub, G., Biollaz, J., Buclin, T., Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS 15 (2001), 71\u201375.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035808574",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "71",
                                    "@last": "75"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Marzolini",
                                    "ce:indexed-name": "Marzolini C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Telenti",
                                    "ce:indexed-name": "Telenti A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Decosterd",
                                    "ce:indexed-name": "Decosterd L.A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Greub",
                                    "ce:indexed-name": "Greub G."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Biollaz",
                                    "ce:indexed-name": "Biollaz J."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Buclin",
                                    "ce:indexed-name": "Buclin T."
                                }
                            ]},
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Marzolini C, Telenti A, Decosterd LA, Greub G, Biollaz J, Buclin T. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS 2001;15:71-75."
                    },
                    {
                        "ref-fulltext": "Clifford, D.B., Evans, S., Yang, Y., et al. Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med 143 (2005), 714\u2013721.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "28144452516",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "143"},
                                "pagerange": {
                                    "@first": "714",
                                    "@last": "721"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Clifford",
                                        "ce:indexed-name": "Clifford D.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Evans",
                                        "ce:indexed-name": "Evans S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Intern Med"
                        },
                        "ce:source-text": "Clifford DB, Evans S, Yang Y, et al. Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med 2005;143:714-721."
                    },
                    {
                        "ref-fulltext": "Csajka, C., Marzolini, C., Fattinger, K., et al. Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection. Clin Pharmacol Ther 73 (2003), 20\u201330.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0037256015",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "20",
                                    "@last": "30"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Csajka",
                                        "ce:indexed-name": "Csajka C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Marzolini",
                                        "ce:indexed-name": "Marzolini C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Fattinger",
                                        "ce:indexed-name": "Fattinger K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacol Ther"
                        },
                        "ce:source-text": "Csajka C, Marzolini C, Fattinger K, et al. Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection. Clin Pharmacol Ther 2003;73:20-30."
                    },
                    {
                        "ref-fulltext": "Pfister, M., Labbe, L., Hammer, S.M., et al. Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: adult AIDS clinical trial group study 398. Antimicrob Agents Chemother 47 (2003), 130\u2013137.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: adult AIDS clinical trial group study 398"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0037226529",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "47"},
                                "pagerange": {
                                    "@first": "130",
                                    "@last": "137"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Pfister",
                                        "ce:indexed-name": "Pfister M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Labbe",
                                        "ce:indexed-name": "Labbe L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Hammer",
                                        "ce:indexed-name": "Hammer S.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Pfister M, Labbe L, Hammer SM, et al. Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: adult AIDS clinical trial group study 398. Antimicrob Agents Chemother 2003;47:130-137."
                    },
                    {
                        "ref-fulltext": "Kappelhoff, B.S., Huitema, A.D., Yalvac, Z., et al. Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals. Clin Pharmacokinet 44 (2005), 849\u2013861.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "20044388655",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "849",
                                    "@last": "861"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kappelhoff",
                                        "ce:indexed-name": "Kappelhoff B.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Huitema",
                                        "ce:indexed-name": "Huitema A.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Yalvac",
                                        "ce:indexed-name": "Yalvac Z."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        },
                        "ce:source-text": "Kappelhoff BS, Huitema AD, Yalvac Z, et al. Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals. Clin Pharmacokinet 2005;44:849-861."
                    },
                    {
                        "ref-fulltext": "Nyakutira, C., Roshammar, D., Chigutsa, E., et al. High prevalence of the CYP2B6 516G-->T(â6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe. Eur J Clin Pharmacol 64 (2008), 357\u2013365.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "High prevalence of the CYP2B6 516G-->T(â6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "40049092364",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "357",
                                    "@last": "365"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Nyakutira",
                                        "ce:indexed-name": "Nyakutira C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Roshammar",
                                        "ce:indexed-name": "Roshammar D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Chigutsa",
                                        "ce:indexed-name": "Chigutsa E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Clin Pharmacol"
                        },
                        "ce:source-text": "Nyakutira C, Roshammar D, Chigutsa E, et al. High prevalence of the CYP2B6 516G-->T(â6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe. Eur J Clin Pharmacol 2008;64:357-365."
                    },
                    {
                        "ref-fulltext": "Mukonzo, J.K., Roshammar, D., Waako, P., et al. A novel polymorphism in ABCB1 gene, CYP2B6â6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans. Br J Clin Pharmacol 68 (2009), 690\u2013699.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "A novel polymorphism in ABCB1 gene, CYP2B6â6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "70449334327",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "690",
                                    "@last": "699"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Mukonzo",
                                        "ce:indexed-name": "Mukonzo J.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Roshammar",
                                        "ce:indexed-name": "Roshammar D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Waako",
                                        "ce:indexed-name": "Waako P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Clin Pharmacol"
                        },
                        "ce:source-text": "Mukonzo JK, Roshammar D, Waako P, et al. A novel polymorphism in ABCB1 gene, CYP2B6â6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans. Br J Clin Pharmacol 2009;68:690-699."
                    },
                    {
                        "ref-fulltext": "Arab-Alameddine, M., Di Iulio, J., Buclin, T., et al. Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals. Clin Pharmacol Ther 85 (2009), 485\u2013494.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "67349205036",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "85"},
                                "pagerange": {
                                    "@first": "485",
                                    "@last": "494"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Arab-Alameddine",
                                        "ce:indexed-name": "Arab-Alameddine M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Di Iulio",
                                        "ce:indexed-name": "Di Iulio J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Buclin",
                                        "ce:indexed-name": "Buclin T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacol Ther"
                        },
                        "ce:source-text": "Arab-Alameddine M, Di Iulio J, Buclin T, et al. Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals. Clin Pharmacol Ther 2009;85:485-494."
                    },
                    {
                        "ref-fulltext": "Sanchez, A., Cabrera, S., Santos, D., et al. Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients. Antimicrob Agents Chemother 55 (2011), 5314\u20135324.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80054699859",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "55"},
                                "pagerange": {
                                    "@first": "5314",
                                    "@last": "5324"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sanchez",
                                        "ce:indexed-name": "Sanchez A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Cabrera",
                                        "ce:indexed-name": "Cabrera S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Santos",
                                        "ce:indexed-name": "Santos D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Sanchez A, Cabrera S, Santos D, et al. Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients. Antimicrob Agents Chemother 2011;55:5314-5324."
                    },
                    {
                        "ref-fulltext": "Ngaimisi, E., Habtewold, A., Minzi, O., et al. Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations. PLoS One, 8, 2013, e67946.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84879813185",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "e67946"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Ngaimisi",
                                        "ce:indexed-name": "Ngaimisi E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Habtewold",
                                        "ce:indexed-name": "Habtewold A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Minzi",
                                        "ce:indexed-name": "Minzi O."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Ngaimisi E, Habtewold A, Minzi O, et al. Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations. PLoS One 2013;8:e67946."
                    },
                    {
                        "ref-fulltext": "Dhoro, M., Zvada, S., Ngara, B., et al. CYP2B6â6, CYP2B6â18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe. BMC Pharmacol Toxicol, 16, 2015, 4.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "CYP2B6â6, CYP2B6â18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84938885862",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {"@first": "4"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Dhoro",
                                        "ce:indexed-name": "Dhoro M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Zvada",
                                        "ce:indexed-name": "Zvada S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Ngara",
                                        "ce:indexed-name": "Ngara B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Pharmacol Toxicol"
                        },
                        "ce:source-text": "Dhoro M, Zvada S, Ngara B, et al. CYP2B6â6, CYP2B6â18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe. BMC Pharmacol Toxicol 2015;16:4."
                    },
                    {
                        "ref-fulltext": "Hui, K.H., Lee, S.S., Lam, T.N., Dose optimization of efavirenz based on individual CYP2B6 polymorphisms in Chinese patients positive for HIV. CPT Pharmacometrics Syst Pharmacol 5 (2016), 182\u2013191.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Dose optimization of efavirenz based on individual CYP2B6 polymorphisms in Chinese patients positive for HIV"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84963642377",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "182",
                                    "@last": "191"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Hui",
                                    "ce:indexed-name": "Hui K.H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee S.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Lam",
                                    "ce:indexed-name": "Lam T.N."
                                }
                            ]},
                            "ref-sourcetitle": "CPT Pharmacometrics Syst Pharmacol"
                        },
                        "ce:source-text": "Hui KH, Lee SS, Lam TN. Dose optimization of efavirenz based on individual CYP2B6 polymorphisms in Chinese patients positive for HIV. CPT Pharmacometrics Syst Pharmacol 2016;5:182-191."
                    },
                    {
                        "ref-fulltext": "Robarge, J.D., Metzger, I.F., Lu, J., et al. Population pharmacokinetic modeling to estimate the contributions of genetic and nongenetic factors to efavirenz disposition. Antimicrob Agents Chemother 61 (2017), e01813\u2013e01816.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetic modeling to estimate the contributions of genetic and nongenetic factors to efavirenz disposition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85009285031",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "e01813",
                                    "@last": "e01816"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Robarge",
                                        "ce:indexed-name": "Robarge J.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Metzger",
                                        "ce:indexed-name": "Metzger I.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Robarge JD, Metzger IF, Lu J, et al. Population pharmacokinetic modeling to estimate the contributions of genetic and nongenetic factors to efavirenz disposition. Antimicrob Agents Chemother 2017;61:e01813-e01816."
                    },
                    {
                        "ref-fulltext": "Uttayamakul, S., Likanonsakul, S., Manosuthi, W., et al. Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults. AIDS Res Ther, 7, 2010, 8.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77950400978",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "8"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Uttayamakul",
                                        "ce:indexed-name": "Uttayamakul S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Likanonsakul",
                                        "ce:indexed-name": "Likanonsakul S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Manosuthi",
                                        "ce:indexed-name": "Manosuthi W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS Res Ther"
                        },
                        "ce:source-text": "Uttayamakul S, Likanonsakul S, Manosuthi W, et al. Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults. AIDS Res Ther 2010;7:8."
                    },
                    {
                        "ref-fulltext": "Sukasem, C., Cressey, T.R., Prapaithong, P., et al. Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults. Br J Clin Pharmacol 74 (2012), 1005\u20131012.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84869010225",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "74"},
                                "pagerange": {
                                    "@first": "1005",
                                    "@last": "1012"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Sukasem",
                                        "ce:indexed-name": "Sukasem C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Cressey",
                                        "ce:indexed-name": "Cressey T.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Prapaithong",
                                        "ce:indexed-name": "Prapaithong P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Clin Pharmacol"
                        },
                        "ce:source-text": "Sukasem C, Cressey TR, Prapaithong P, et al. Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults. Br J Clin Pharmacol 2012;74:1005-1012."
                    },
                    {
                        "ref-fulltext": "Manosuthi, W., Sukasem, C., Lueangniyomkul, A., et al. Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients. Antimicrob Agents Chemother 57 (2013), 1019\u20131024.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84872869312",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "57"},
                                "pagerange": {
                                    "@first": "1019",
                                    "@last": "1024"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Manosuthi",
                                        "ce:indexed-name": "Manosuthi W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Sukasem",
                                        "ce:indexed-name": "Sukasem C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Lueangniyomkul",
                                        "ce:indexed-name": "Lueangniyomkul A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Manosuthi W, Sukasem C, Lueangniyomkul A, et al. Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients. Antimicrob Agents Chemother 2013;57:1019-1024."
                    },
                    {
                        "ref-fulltext": "Sukasem, C., Chamnanphon, M., Koomdee, N., et al. High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections. Drug Metab Pharmacokinet 28 (2013), 391\u2013397.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84880504005",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "391",
                                    "@last": "397"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Sukasem",
                                        "ce:indexed-name": "Sukasem C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Chamnanphon",
                                        "ce:indexed-name": "Chamnanphon M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Koomdee",
                                        "ce:indexed-name": "Koomdee N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Metab Pharmacokinet"
                        },
                        "ce:source-text": "Sukasem C, Chamnanphon M, Koomdee N, et al. High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections. Drug Metab Pharmacokinet 2013;28:391-397."
                    },
                    {
                        "ref-fulltext": "Cabrera, S.E., Santos, D., Valverde, M.P., et al. Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients. Antimicrob Agents Chemother 53 (2009), 2791\u20132798.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "67649960169",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "53"},
                                "pagerange": {
                                    "@first": "2791",
                                    "@last": "2798"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Cabrera",
                                        "ce:indexed-name": "Cabrera S.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Santos",
                                        "ce:indexed-name": "Santos D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Valverde",
                                        "ce:indexed-name": "Valverde M.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Cabrera SE, Santos D, Valverde MP, et al. Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients. Antimicrob Agents Chemother 2009;53:2791-2798."
                    },
                    {
                        "ref-fulltext": "Gallien, S., Journot, V., Loriot, M.A., et al. Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms: a substudy of the ANRS ALIZE trial. HIV Med 18 (2017), 537\u2013545.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms: a substudy of the ANRS ALIZE trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85026725640",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "537",
                                    "@last": "545"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Gallien",
                                        "ce:indexed-name": "Gallien S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Journot",
                                        "ce:indexed-name": "Journot V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Loriot",
                                        "ce:indexed-name": "Loriot M.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "HIV Med"
                        },
                        "ce:source-text": "Gallien S, Journot V, Loriot MA, et al. Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms: a substudy of the ANRS ALIZE trial. HIV Med 2017;18:537-545."
                    },
                    {
                        "ref-fulltext": "Leger, P., Chirwa, S., Turner, M., et al. Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race. Pharmacogenet Genomics 26 (2016), 473\u2013480.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84981268326",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "473",
                                    "@last": "480"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Leger",
                                        "ce:indexed-name": "Leger P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Chirwa",
                                        "ce:indexed-name": "Chirwa S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Turner",
                                        "ce:indexed-name": "Turner M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenet Genomics"
                        },
                        "ce:source-text": "Leger P, Chirwa S, Turner M, et al. Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race. Pharmacogenet Genomics 2016;26:473-480."
                    },
                    {
                        "ref-fulltext": "Dickinson, L., Amin, J., Else, L., et al. Comprehensive pharmacokinetic, pharmacodynamic and pharmacogenetic evaluation of once-daily efavirenz 400 and 600 mg in treatment-naive HIV-infected patients at 96 weeks: results of the ENCORE1 study. Clin Pharmacokinet 55 (2016), 861\u2013873.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Comprehensive pharmacokinetic, pharmacodynamic and pharmacogenetic evaluation of once-daily efavirenz 400 and 600 mg in treatment-naive HIV-infected patients at 96 weeks: results of the ENCORE1 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84952053015",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "55"},
                                "pagerange": {
                                    "@first": "861",
                                    "@last": "873"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Dickinson",
                                        "ce:indexed-name": "Dickinson L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Amin",
                                        "ce:indexed-name": "Amin J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Else",
                                        "ce:indexed-name": "Else L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        },
                        "ce:source-text": "Dickinson L, Amin J, Else L, et al. Comprehensive pharmacokinetic, pharmacodynamic and pharmacogenetic evaluation of once-daily efavirenz 400 and 600 mg in treatment-naive HIV-infected patients at 96 weeks: results of the ENCORE1 study. Clin Pharmacokinet 2016;55:861-873."
                    },
                    {
                        "ref-fulltext": "Haas, D.W., Ribaudo, H.J., Kim, R.B., et al. Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS 18 (2004), 2391\u20132400.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "19944428456",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "2391",
                                    "@last": "2400"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Haas",
                                        "ce:indexed-name": "Haas D.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ribaudo",
                                        "ce:indexed-name": "Ribaudo H.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim R.B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Haas DW, Ribaudo HJ, Kim RB, et al. Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS 2004;18:2391-2400."
                    },
                    {
                        "ref-fulltext": "ENCORE1 Study Group, Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial. Lancet. 383 (2014), 1474\u20131482.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84899620845",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "383"},
                                "pagerange": {
                                    "@first": "1474",
                                    "@last": "1482"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "@_fa": "true",
                                "ce:surname": "ENCORE1 Study Group",
                                "ce:indexed-name": "ENCORE1 Study Group"
                            }]},
                            "ref-sourcetitle": "Lancet."
                        },
                        "ce:source-text": "ENCORE1 Study Group. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial. Lancet. 2014;383:1474-1482."
                    },
                    {
                        "ref-fulltext": "Group, E.S., Carey, D., Puls, R., et al. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study. Lancet Infect Dis 15 (2015), 793\u2013802.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84937512973",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "793",
                                    "@last": "802"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Group",
                                        "ce:indexed-name": "Group E.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Carey",
                                        "ce:indexed-name": "Carey D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Puls",
                                        "ce:indexed-name": "Puls R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Infect Dis"
                        },
                        "ce:source-text": "Group ES, Carey D, Puls R, et al. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study. Lancet Infect Dis 2015;15:793-802."
                    },
                    {
                        "ref-fulltext": "Gatanaga, H., Hayashida, T., Tsuchiya, K., et al. Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 â6 and â26. Clin Infect Dis 45 (2007), 1230\u20131237.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 â6 and â26"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "35348923463",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "1230",
                                    "@last": "1237"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Gatanaga",
                                        "ce:indexed-name": "Gatanaga H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Hayashida",
                                        "ce:indexed-name": "Hayashida T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Tsuchiya",
                                        "ce:indexed-name": "Tsuchiya K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Gatanaga H, Hayashida T, Tsuchiya K, et al. Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 â6 and â26. Clin Infect Dis 2007;45:1230-1237."
                    },
                    {
                        "ref-fulltext": "Fayet Mello, A., Buclin, T., Decosterd, L.A., et al. Successful efavirenz dose reduction guided by therapeutic drug monitoring. Antivir Ther 16 (2011), 189\u2013197.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Successful efavirenz dose reduction guided by therapeutic drug monitoring"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79953182674",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "189",
                                    "@last": "197"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Fayet Mello",
                                        "ce:indexed-name": "Fayet Mello A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Buclin",
                                        "ce:indexed-name": "Buclin T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Decosterd",
                                        "ce:indexed-name": "Decosterd L.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antivir Ther"
                        },
                        "ce:source-text": "Fayet Mello A, Buclin T, Decosterd LA, et al. Successful efavirenz dose reduction guided by therapeutic drug monitoring. Antivir Ther 2011;16:189-197."
                    },
                    {
                        "ref-fulltext": "Cabrera Figueroa, S., Iglesias Gomez, A., Sanchez Martin, A., de la Paz Valverde Merino M, Dominguez-Gil Hurle A, Cordero Sanchez M. Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV. Clin Drug Investig 30 (2010), 405\u2013411.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "de la Paz Valverde Merino M, Dominguez-Gil Hurle A, Cordero Sanchez M. Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77952017936",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "405",
                                    "@last": "411"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Cabrera Figueroa",
                                    "ce:indexed-name": "Cabrera Figueroa S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Iglesias Gomez",
                                    "ce:indexed-name": "Iglesias Gomez A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sanchez Martin",
                                    "ce:indexed-name": "Sanchez Martin A."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Drug Investig"
                        },
                        "ce:source-text": "Cabrera Figueroa S, Iglesias Gomez A, Sanchez Martin A, de la Paz Valverde Merino M, Dominguez-Gil Hurle A, Cordero Sanchez M. Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV. Clin Drug Investig 2010;30:405-411."
                    },
                    {
                        "ref-fulltext": "Sukasem, C., Manosuthi, W., Koomdee, N., et al. Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism. Infection 42 (2014), 469\u2013474.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84901648608",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "469",
                                    "@last": "474"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Sukasem",
                                        "ce:indexed-name": "Sukasem C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Manosuthi",
                                        "ce:indexed-name": "Manosuthi W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Koomdee",
                                        "ce:indexed-name": "Koomdee N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Infection"
                        },
                        "ce:source-text": "Sukasem C, Manosuthi W, Koomdee N, et al. Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism. Infection 2014;42:469-474."
                    },
                    {
                        "ref-fulltext": "Lang, T., Klein, K., Fischer, J., et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 11 (2001), 399\u2013415.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0034948077",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "399",
                                    "@last": "415"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Lang",
                                        "ce:indexed-name": "Lang T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Klein",
                                        "ce:indexed-name": "Klein K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Fischer",
                                        "ce:indexed-name": "Fischer J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenetics"
                        },
                        "ce:source-text": "Lang T, Klein K, Fischer J, et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 2001;11:399-415."
                    },
                    {
                        "ref-fulltext": "Ette, E.I., Williams, P.J., Kim, Y.H., Lane, J.R., Liu, M.J., Capparelli, E.V., Model appropriateness and population pharmacokinetic modeling. J Clin Pharmacol 43 (2003), 610\u2013623.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Model appropriateness and population pharmacokinetic modeling"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0038243538",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "43"},
                                "pagerange": {
                                    "@first": "610",
                                    "@last": "623"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.I.",
                                    "@_fa": "true",
                                    "ce:surname": "Ette",
                                    "ce:indexed-name": "Ette E.I."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Williams",
                                    "ce:indexed-name": "Williams P.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim Y.H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Lane",
                                    "ce:indexed-name": "Lane J.R."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu M.J."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "E.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Capparelli",
                                    "ce:indexed-name": "Capparelli E.V."
                                }
                            ]},
                            "ref-sourcetitle": "J Clin Pharmacol"
                        },
                        "ce:source-text": "Ette EI, Williams PJ, Kim YH, Lane JR, Liu MJ, Capparelli EV. Model appropriateness and population pharmacokinetic modeling. J Clin Pharmacol 2003;43:610-623."
                    },
                    {
                        "ref-fulltext": "Bergstrand, M., Hooker, A.C., Wallin, J.E., Karlsson, M.O., Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 13 (2011), 143\u2013151.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79957451960",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "143",
                                    "@last": "151"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Bergstrand",
                                    "ce:indexed-name": "Bergstrand M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Hooker",
                                    "ce:indexed-name": "Hooker A.C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Wallin",
                                    "ce:indexed-name": "Wallin J.E."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.O.",
                                    "@_fa": "true",
                                    "ce:surname": "Karlsson",
                                    "ce:indexed-name": "Karlsson M.O."
                                }
                            ]},
                            "ref-sourcetitle": "AAPS J"
                        },
                        "ce:source-text": "Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 2011;13:143-151."
                    },
                    {
                        "ref-fulltext": "Avihingsanon, A., Maek, A.N.W., Gatechompol, S., et al. Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naive and experienced HIV-1-infected Thai adults. Int J Infect Dis 61 (2017), 89\u201396.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naive and experienced HIV-1-infected Thai adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85021683300",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "89",
                                    "@last": "96"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.N.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Maek",
                                        "ce:indexed-name": "Maek A.N.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Gatechompol",
                                        "ce:indexed-name": "Gatechompol S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Infect Dis"
                        },
                        "ce:source-text": "Avihingsanon A, Maek ANW, Gatechompol S, et al. Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naive and experienced HIV-1-infected Thai adults. Int J Infect Dis 2017;61:89-96."
                    },
                    {
                        "ref-fulltext": "Guan, S., Huang, M., Chan, E., Chen, X., Duan, W., Zhou, S.F., Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese. Eur J Pharm Sci 29 (2006), 14\u201321.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib34",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33747789083",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "14",
                                    "@last": "21"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Guan",
                                    "ce:indexed-name": "Guan S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan E."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen X."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Duan",
                                    "ce:indexed-name": "Duan W."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou S.F."
                                }
                            ]},
                            "ref-sourcetitle": "Eur J Pharm Sci"
                        },
                        "ce:source-text": "Guan S, Huang M, Chan E, Chen X, Duan W, Zhou SF. Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese. Eur J Pharm Sci 2006;29:14-21."
                    },
                    {
                        "ref-fulltext": "Guan, S., Huang, M., Li, X., Chen, X., Chan, E., Zhou, S.F., Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese. Pharm Res 23 (2006), 1983\u20131990.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib35",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33750592308",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "1983",
                                    "@last": "1990"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Guan",
                                    "ce:indexed-name": "Guan S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li X."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen X."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan E."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou S.F."
                                }
                            ]},
                            "ref-sourcetitle": "Pharm Res"
                        },
                        "ce:source-text": "Guan S, Huang M, Li X, Chen X, Chan E, Zhou SF. Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese. Pharm Res 2006;23:1983-1990."
                    },
                    {
                        "ref-fulltext": "Davaalkham, J., Hayashida, T., Tsuchiya, K., Gatanaga, H., Nyamkhuu, D., Oka, S., Allele and genotype frequencies of cytochrome P450 2B6 gene in a Mongolian population. Drug Metab Dispos 37 (2009), 1991\u20131993.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Allele and genotype frequencies of cytochrome P450 2B6 gene in a Mongolian population"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib36",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "70349295980",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "1991",
                                    "@last": "1993"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Davaalkham",
                                    "ce:indexed-name": "Davaalkham J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Hayashida",
                                    "ce:indexed-name": "Hayashida T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Tsuchiya",
                                    "ce:indexed-name": "Tsuchiya K."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Gatanaga",
                                    "ce:indexed-name": "Gatanaga H."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Nyamkhuu",
                                    "ce:indexed-name": "Nyamkhuu D."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Oka",
                                    "ce:indexed-name": "Oka S."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab Dispos"
                        },
                        "ce:source-text": "Davaalkham J, Hayashida T, Tsuchiya K, Gatanaga H, Nyamkhuu D, Oka S. Allele and genotype frequencies of cytochrome P450 2B6 gene in a Mongolian population. Drug Metab Dispos 2009;37:1991-1993."
                    },
                    {
                        "ref-fulltext": "Meng, X., Yin, K., Wang, J., et al. Effect of CYP2B6 gene polymorphisms on efavirenz plasma concentrations in Chinese patients with HIV infection. PLoS One, 10, 2015, e0130583.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Effect of CYP2B6 gene polymorphisms on efavirenz plasma concentrations in Chinese patients with HIV infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib37",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84939222777",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "e0130583"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Meng",
                                        "ce:indexed-name": "Meng X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Yin",
                                        "ce:indexed-name": "Yin K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Meng X, Yin K, Wang J, et al. Effect of CYP2B6 gene polymorphisms on efavirenz plasma concentrations in Chinese patients with HIV infection. PLoS One 2015;10:e0130583."
                    },
                    {
                        "ref-fulltext": "To, K.W., Liu, S.T., Cheung, S.W., Chan, D.P., Chan, R.C., Lee, S.S., Pharmacokinetics of plasma efavirenz and CYP2B6 polymorphism in southern Chinese. Ther Drug Monit 31 (2009), 527\u2013530.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Pharmacokinetics of plasma efavirenz and CYP2B6 polymorphism in southern Chinese"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib38",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "68449090722",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "527",
                                    "@last": "530"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.W.",
                                    "@_fa": "true",
                                    "ce:surname": "To",
                                    "ce:indexed-name": "To K.W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu S.T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheung",
                                    "ce:indexed-name": "Cheung S.W."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan D.P."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan R.C."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee S.S."
                                }
                            ]},
                            "ref-sourcetitle": "Ther Drug Monit"
                        },
                        "ce:source-text": "To KW, Liu ST, Cheung SW, Chan DP, Chan RC, Lee SS. Pharmacokinetics of plasma efavirenz and CYP2B6 polymorphism in southern Chinese. Ther Drug Monit 2009;31:527-530."
                    },
                    {
                        "ref-fulltext": "Manosuthi, W., Sungkanuparph, S., Tantanathip, P., et al. Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin. Antimicrob Agents Chemother 53 (2009), 4545\u20134548.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib39",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "70349313476",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "53"},
                                "pagerange": {
                                    "@first": "4545",
                                    "@last": "4548"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Manosuthi",
                                        "ce:indexed-name": "Manosuthi W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Sungkanuparph",
                                        "ce:indexed-name": "Sungkanuparph S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Tantanathip",
                                        "ce:indexed-name": "Tantanathip P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Manosuthi W, Sungkanuparph S, Tantanathip P, et al. Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin. Antimicrob Agents Chemother 2009;53:4545-4548."
                    },
                    {
                        "ref-fulltext": "Matteelli, A., Regazzi, M., Villani, P., et al. Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients. Curr HIV Res 5 (2007), 349\u2013353.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib40",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34249069242",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "349",
                                    "@last": "353"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Matteelli",
                                        "ce:indexed-name": "Matteelli A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Regazzi",
                                        "ce:indexed-name": "Regazzi M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Villani",
                                        "ce:indexed-name": "Villani P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr HIV Res"
                        },
                        "ce:source-text": "Matteelli A, Regazzi M, Villani P, et al. Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients. Curr HIV Res 2007;5:349-353."
                    },
                    {
                        "ref-fulltext": "Lopez-Cortes, L.F., Ruiz-Valderas, R., Viciana, P., et al. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis. Clin Pharmacokinet 41 (2002), 681\u2013690.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib41",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0036060766",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "681",
                                    "@last": "690"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Lopez-Cortes",
                                        "ce:indexed-name": "Lopez-Cortes L.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Ruiz-Valderas",
                                        "ce:indexed-name": "Ruiz-Valderas R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Viciana",
                                        "ce:indexed-name": "Viciana P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        },
                        "ce:source-text": "Lopez-Cortes LF, Ruiz-Valderas R, Viciana P, et al. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis. Clin Pharmacokinet 2002;41:681-690."
                    },
                    {
                        "ref-fulltext": "Kwara, A., Lartey, M., Sagoe, K.W.C., Kenu, E., Court, M.H., CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients. AIDS 23 (2009), 2101\u20132106.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib42",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77952322356",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "2101",
                                    "@last": "2106"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kwara",
                                    "ce:indexed-name": "Kwara A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Lartey",
                                    "ce:indexed-name": "Lartey M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.W.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Sagoe",
                                    "ce:indexed-name": "Sagoe K.W.C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Kenu",
                                    "ce:indexed-name": "Kenu E."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Court",
                                    "ce:indexed-name": "Court M.H."
                                }
                            ]},
                            "ref-sourcetitle": "AIDS"
                        },
                        "ce:source-text": "Kwara A, Lartey M, Sagoe KWC, Kenu E, Court MH. CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients. AIDS 2009;23:2101-2106."
                    },
                    {
                        "ref-fulltext": "Soeria-Atmadja, S., Ãsterberg, E., Gustafsson, L.L., et al. Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin. PLoS One, 12, 2017, e0181316.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib43",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85029305135",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "e0181316"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Soeria-Atmadja",
                                        "ce:indexed-name": "Soeria-Atmadja S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Ãsterberg",
                                        "ce:indexed-name": "Osterberg E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Gustafsson",
                                        "ce:indexed-name": "Gustafsson L.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Soeria-Atmadja S, Osterberg E, Gustafsson LL, et al. Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin. PLoS One 2017;12:e0181316."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85085047562",
        "dc:description": "Purpose: Efavirenz exhibits high interindividual variability in plasma concentrations, leading to unpredictable efficacy and toxicity. Polymorphism of CYP2B6 516G > T has been found to predominantly contribute to efavirenz variability. However, dosage recommendations incorporating CYP2B6 516G > T polymorphism have not been investigated in the Thai population. This study aimed to develop a population model of the pharmacokinetic properties of efavirenz, and to investigate the impact of patients' characteristics and CYP2B6 516G > T polymorphism on the pharmacokinetic properties of efavirenz. Model-based simulations were performed to provide genotype-based dosage optimization in a Thai population. Methods: Plasma efavirenz concentrations measured at 12 h post-dose in 360 Thai HIV-infected patients with and without tuberculosis were analyzed by the nonlinear mixed-effects modeling approach. A 1-compartment model with first-order absorption and elimination was used for describing the pharmacokinetic properties of efavirenz. Findings: The allele frequency of CYP2B6 516G > T was 34.17%. The efavirenz oral clearance were 11.9, 8.0, and 2.8 L/h in patients weighing 57 kg and having the CYP2B6 516 GG, 516 GT, and 516 TT genotypes, respectively. The use of rifampicin increased efavirenz oral clearance by 28%. The results from the simulations suggest that efavirenz dosages of 400, 300, and 100 mg once daily in Thai HIV mono-infected patients, and 800, 600, and 200 mg once daily in HIV/tuberculosis co-infected patients carrying CYP2B6 516 GG, 516 GT, and 516 TT, respectively. Implication: The results from this study provide a rationale for efavirenz dose adjustment based on CYP2B6 516G > T polymorphism in Thai HIV-infected patients, which could help to improve treatment outcomes in this population. ClinicalTrials.gov identifier: NCT01138267.",
        "pubmed-id": "32451120",
        "prism:coverDate": "2020-07-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85085047562",
        "dc:creator": {"author": [{
            "ce:given-name": "Piyawat",
            "preferred-name": {
                "ce:given-name": "Piyawat",
                "ce:initials": "P.",
                "ce:surname": "Chaivichacharn",
                "ce:indexed-name": "Chaivichacharn P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000881",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
            },
            "ce:degrees": "PharmD",
            "ce:surname": "Chaivichacharn",
            "@auid": "57216855353",
            "author-url": "https://api.elsevier.com/content/author/author_id/57216855353",
            "ce:indexed-name": "Chaivichacharn P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85085047562"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085047562&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85085047562&origin=inward"
            }
        ],
        "source-id": "29712",
        "pii": "S0149291820302319",
        "citedby-count": "5",
        "prism:volume": "42",
        "subtype": "ar",
        "dc:title": "Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic\u2013Pharmacogenetic Model of HIV-infected Patients in Thailand",
        "openaccess": "0",
        "prism:issn": "1879114X 01492918",
        "publishercopyright": "Â© 2020 Elsevier Inc.",
        "prism:issueIdentifier": "7",
        "subtypeDescription": "Article",
        "prism:publicationName": "Clinical Therapeutics",
        "prism:pageRange": "1234-1245",
        "prism:endingPage": "1245",
        "openaccessFlag": "false",
        "prism:doi": "10.1016/j.clinthera.2020.04.013",
        "prism:startingPage": "1234",
        "dc:identifier": "SCOPUS_ID:85085047562",
        "dc:publisher": "Excerpta Medica Inc."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Alkynes",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Anti-HIV Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Benzoxazines",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cross-Sectional Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cyclopropanes",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cytochrome P-450 CYP2B6",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Genotype",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV Infections",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Models, Biological",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Pharmacogenetics",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Young Adult",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "CYP2B6 516G>T"
        },
        {
            "@_fa": "true",
            "$": "Dose optimization"
        },
        {
            "@_fa": "true",
            "$": "Efavirenz"
        },
        {
            "@_fa": "true",
            "$": "HIV"
        },
        {
            "@_fa": "true",
            "$": "Population pharmacokinetics\u2013pharmacogenetics"
        },
        {
            "@_fa": "true",
            "$": "Thailand"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Piyawat",
            "preferred-name": {
                "ce:given-name": "Piyawat",
                "ce:initials": "P.",
                "ce:surname": "Chaivichacharn",
                "ce:indexed-name": "Chaivichacharn P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000881",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
            },
            "ce:degrees": "PharmD",
            "ce:surname": "Chaivichacharn",
            "@auid": "57216855353",
            "author-url": "https://api.elsevier.com/content/author/author_id/57216855353",
            "ce:indexed-name": "Chaivichacharn P."
        },
        {
            "ce:given-name": "Anchalee",
            "preferred-name": {
                "ce:given-name": "Anchalee",
                "ce:initials": "A.",
                "ce:surname": "Avihingsanon",
                "ce:indexed-name": "Avihingsanon A."
            },
            "@seq": "2",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60016965",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:degrees": "MD, PhD",
            "ce:surname": "Avihingsanon",
            "@auid": "57196347321",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196347321",
            "ce:indexed-name": "Avihingsanon A."
        },
        {
            "ce:given-name": "Weerawat",
            "preferred-name": {
                "ce:given-name": "Weerawat",
                "ce:initials": "W.",
                "ce:surname": "Manosuthi",
                "ce:indexed-name": "Manosuthi W."
            },
            "@seq": "3",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015728",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728"
            },
            "ce:degrees": "MD",
            "ce:surname": "Manosuthi",
            "@auid": "57225766218",
            "author-url": "https://api.elsevier.com/content/author/author_id/57225766218",
            "ce:indexed-name": "Manosuthi W."
        },
        {
            "ce:given-name": "Sasiwimol",
            "preferred-name": {
                "ce:given-name": "Sasiwimol",
                "ce:initials": "S.",
                "ce:surname": "Ubolyam",
                "ce:indexed-name": "Ubolyam S."
            },
            "@seq": "4",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016965",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Ubolyam",
            "@auid": "6602454026",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602454026",
            "ce:indexed-name": "Ubolyam S."
        },
        {
            "ce:given-name": "Siraprapa",
            "preferred-name": {
                "ce:given-name": "Siraprapa",
                "ce:initials": "S.",
                "ce:surname": "Tongkobpetch",
                "ce:indexed-name": "Tongkobpetch S."
            },
            "@seq": "5",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                }
            ],
            "ce:degrees": "PhD",
            "ce:surname": "Tongkobpetch",
            "@auid": "6504831231",
            "author-url": "https://api.elsevier.com/content/author/author_id/6504831231",
            "ce:indexed-name": "Tongkobpetch S."
        },
        {
            "ce:given-name": "Vorasuk",
            "preferred-name": {
                "ce:given-name": "Vorasuk",
                "ce:initials": "V.",
                "ce:surname": "Shotelersuk",
                "ce:indexed-name": "Shotelersuk V."
            },
            "@seq": "6",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Shotelersuk",
            "@auid": "7003738743",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003738743",
            "ce:indexed-name": "Shotelersuk V."
        },
        {
            "ce:given-name": "Baralee",
            "preferred-name": {
                "ce:given-name": "Baralee",
                "ce:initials": "B.",
                "ce:surname": "Punyawudho",
                "ce:indexed-name": "Punyawudho B."
            },
            "@seq": "7",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000881",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Punyawudho",
            "@auid": "23976628300",
            "author-url": "https://api.elsevier.com/content/author/author_id/23976628300",
            "ce:indexed-name": "Punyawudho B."
        }
    ]}
}}